Support for developing new cancer drugs and therapies
Official title: IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP
Funded at Technical Resources International, INC. · NIH-11110272 · Data updated 2026-11-12
This study is all about helping to create new cancer treatments by making sure everything is done right and safely during the testing process, so that patients can get better options for their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Technical Resources International, INC. NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $8,017,011 |
| NIH project number | 75N91022C00014-P00004-9999-1 |
| Project ID | NIH-11110272 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who may be eligible for new investigational therapies.
✕Less likely to help
Patients with non-cancerous conditions or those not eligible for clinical trials may not receive any benefit from this research.
What this research studies
This research focuses on providing essential support services to the Cancer Therapy Evaluation Program (CTEP) to facilitate the development of new cancer drugs. It involves preparing and submitting necessary documents to the FDA, tracking investigational anti-cancer agents, and monitoring safety and adverse events during clinical trials. By ensuring compliance with regulatory requirements and supporting collaborations with pharmaceutical companies, this initiative aims to streamline the drug development process for cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to the faster development and approval of new cancer treatments, improving outcomes for patients.
How similar studies have gone: Previous research has shown success in similar approaches, indicating that structured support for drug development can lead to significant advancements in cancer treatment.
Where this research is happening
-
Technical Resources International, INC.
Bethesda, United States Active
Researchers
- Principal investigator: Miller, Lauren — Technical Resources International, INC.
- Study coordinator: Miller, Lauren
Related research
Other NIH-funded projects on the same topics.
-
Support for research on antibiotic resistance
This program is here to help researchers find better ways to fight infections that don't respond to antibiotics by providing support, training, and making sure everything is done safely and correctly.
-
Support for clinical research operations and management
This study is all about making clinical trials better and safer for patients by providing researchers with the support and training they need, so you can feel confident that the research is being done right and could lead to better treatments for you.
-
Improving data collection for HIV and HPV prevention trials in the Americas
This study is working to make it easier and more reliable to gather and manage information from clinical trials that help prevent HIV and HPV, so that people in the US, Latin America, and the Caribbean can participate more easily and effectively in these important health studies.
-
Support for regulatory activities in clinical research
This study is all about helping make sure that clinical research is done the right way, so new treatments can get to patients faster and more safely.
-
Evaluating immune modulator drugs for COVID-19 treatment in hospitalized adults
This study is looking at how well three different immune system drugs work for treating COVID-19 by collecting and analyzing samples from adults in the hospital, and your participation could help us understand their safety and benefits for patients like you.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.